Trials / Completed
CompletedNCT04579419
Injection Site Pain Botulinum Toxin Reconstituted in NS With and Without Sodium Bicarbonate
Injection Site Pain, Onset and Duration of Action of Botulinum Toxin Reconstituted in Normal Saline With and Without Sodium Bicarbonate; A Prospective, Single Center, Randomized, Double-Blind Interventional Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- King Abdulaziz Medical City · Other Government
- Sex
- Female
- Age
- 25 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to investigate the effects of botulinum toxin type A injections diluted with the mixture of sodium bicarbonate (SB) and normal saline (NS) on pain reduction, onset of action and duration of action. This is a prospective, randomized, double-blind clinical study, which included 30 female patients (age\>25). The patients were randomized to receive botulinum toxin (BT) injections diluted with NS and SB on one side of the face and saline control injections on the other side. Pain severity was assessed using visual analogue scale. The onset and duration of action were recorded according to the patients' subjective opinions after 1 week and 3 months, respectively. The study was approved with an IRB (Institutional Review Board) number of RC19/371.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Bicarbonate | Botulinum Toxin diluted in Sodium Bicarbonate |
| DRUG | Normal Saline | 0.9 NaCl |
Timeline
- Start date
- 2019-11-09
- Primary completion
- 2020-08-09
- Completion
- 2020-08-09
- First posted
- 2020-10-08
- Last updated
- 2020-10-08
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT04579419. Inclusion in this directory is not an endorsement.